Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Two Anti-angiogenesis Drugs（Endostar and Thalidomide）
Pure chemotherapy（Xelox）
Locations
3
China
Anhui Cancer Hospital
Hefei, Anhui, China
Anhui Jimin Cancer Hospital
Hefei, Anhui, China
The First People's Hospital of Hefei
Hefei, Anhui, China
Start Date
January 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2018
Last Updated
April 22, 2016
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
The First People's Hospital of Hefei
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions